Related Experiment Video
Updated: Jul 7, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Molecular Mechanisms Linking Diabetes with Increased Risk of Thrombosis
Lucy Batten1,2, Thozhukat Sathyapalan2, Timothy M Palmer1
1Biomedical Institute for Multimorbidity, Centre for Biomedicine, Hull York Medical School, University of Hull, Hull HU6 7RX, UK.
Insights
Poor glycaemic control in diabetes elevates thrombotic risk via unclear molecular mechanisms. This review explores links between hyperglycemia, O-GlcNAcylation, and thrombosis, highlighting areas for future diabetes research.
Area of Science:
- Endocrinology and Metabolism
- Cardiovascular Science
- Molecular Biology
Background:
- Diabetes mellitus is a leading cause of mortality, primarily due to cardiovascular events like stroke and myocardial infarction.
- Increased thrombotic risk, including platelet hyperactivity, hypercoagulability, and endothelial dysfunction, is a significant complication of diabetes.
- The precise molecular pathways connecting poor glycemic control to heightened thrombosis remain incompletely understood.
Purpose of the Study:
- To review current knowledge on mechanisms linking poor glycemic control to increased thrombotic risk in diabetes.
- To elucidate the role of post-translational modifications, specifically O-GlcNAcylation, in diabetes-associated thrombosis.
- To identify gaps in understanding and suggest future research directions.
Main Methods:
- Literature review synthesizing current research on diabetes, thrombosis, and molecular mechanisms.
- Focus on post-translational modifications, particularly O-GlcNAcylation, as a key regulatory pathway.
- Analysis of existing data to highlight the complexity and multifactorial nature of the link.
Main Results:
- Poor glycemic control contributes to thrombotic events through complex, multifactorial molecular mechanisms.
- O-GlcNAcylation is implicated in regulating protein function in diabetes, potentially influencing thrombotic processes.
- The intricate regulation and multiple variables involved make the specific role of O-GlcNAcylation in thrombosis poorly understood.
Conclusions:
- Further research is essential to fully understand the molecular mechanisms linking hyperglycemia and thrombosis in diabetes.
- Investigating the precise impact of O-GlcNAcylation on specific disease processes is crucial for developing targeted therapies.
- Clarifying these pathways could lead to improved prevention and management of cardiovascular complications in diabetic patients.
Abstract:
This review will provide an overview of what is currently known about mechanisms linking poor glycaemic control with increased thrombotic risk. The leading causes of death in people with diabetes are strokes and cardiovascular disease. Significant morbidity is associated with an increased risk of thrombosis, resulting in myocardial infarction, ischaemic stroke, and peripheral vascular disease, along with the sequelae of these events, including loss of functional ability, heart failure, and amputations. While the increased platelet activity, pro-coagulability, and endothelial dysfunction directly impact this risk, the molecular mechanisms linking poor glycaemic control with increased thrombotic risk remain unclear. This review highlights the complex mechanisms underlying thrombosis prevalence in individuals with diabetes and hyperglycaemia. Post-translational modifications, such as O-GlcNAcylation, play a crucial role in controlling protein function in diabetes. However, the role of O-GlcNAcylation remains poorly understood due to its intricate regulation and the potential involvement of multiple variables. Further research is needed to determine the precise impact of O-GlcNAcylation on specific disease processes.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications
Psychoneuroimmunology: Diabetes and Cancer
Anticoagulant Drugs: Low-Molecular-Weight Heparins

